Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20100527004041N22Phase 3Completed
Phase 3, randomised, double-blind trial of ropivacaine, propofol and lidocaine (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 3 more. Started Jun 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20100527004041N22.